UPDATE : Monday, December 9, 2019
상단여백
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo  |  2019-09-16 13:56
라인
GSK’s chronic hand eczema treatment faces local competition
GSK Korea is facing competition from DongKoo Bio&Pharma for its exclusive c...
by Lee Han-soo  |  2019-09-12 07:22
라인
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im  |  2019-09-11 15:16
라인
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
AstraZeneca’s Imfinzi (ingredient: durvalumab) has sharpened up its weapon ...
by Kim Yun-mi  |  2019-09-11 14:18
라인
Amgen fetes 1st anniversary of getting expanded indication for Repatha
Amgen Korea said that its cardio-vascular disease business unit has held an...
by Lee Han-soo  |  2019-09-11 13:56
라인
Hanmi to launch 3-substance combination in Latin America
Hanmi Pharmaceutical said that it has become the first local corporation to...
by Lee Han-soo  |  2019-09-11 13:56
라인
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im  |  2019-09-11 13:56
라인
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im  |  2019-09-10 15:38
라인
Immunotherapies Opdivo, Keytruda score high in real setting
Immunotherapies Opdivo Inj. and Keytruda Inj. showed excellent efficacy and...
by Kim Eun-young  |  2019-09-10 12:49
라인
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’
Bayer said that it has presented two real-world research results that have ...
by Lee Han-soo  |  2019-09-09 16:54
라인
Hanmi to unveil investigator-led P2 progress for cancer treatment
Hanmi said that MD Anderson Cancer Center has presented the development of ...
by Lee Han-soo  |  2019-09-09 15:47
라인
Novo Nordisk's Ryzodeg leads Korean mixed insulin market
Novo Nordisk Korea said Monday that Ryzodeg, the company's soluble insu...
by Lee Han-soo  |  2019-09-09 14:18
라인
PARP inhibitors to show intense rivalry at ESMO 2019
The highlight of the upcoming ESMO 2019, a cancer meeting in Europe, will b...
by Kim Yun-mi  |  2019-09-09 11:56
라인
Ildong to sell GSK’s influenza treatment
Ildong Pharmaceutical said that it would exclusively promote and market GSK...
by Lee Han-soo  |  2019-09-06 17:02
라인
Yuhan to expand biz scope to central nervous system disease
“We will broaden open innovation toward the academic sector and expand our ...
by Jeong Sae-im  |  2019-09-06 14:56
라인
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan
Seoul Pharmaceutical said that it would export $4.9 million worth of its or...
by Lee Han-soo  |  2019-09-05 17:04
라인
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon  |  2019-09-05 16:24
라인
Daewoong, Medytox squabble over appraisal of additional spore for Nabota
Daewoong Pharmaceutical said that a recent test by the U.S. International T...
by Lee Han-soo  |  2019-09-05 14:35
라인
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union
Takeda Korea, which took over Shire Korea in January according to their hea...
by Lee Han-soo  |  2019-09-04 17:06
라인
JW Pharmaceutical acquires Vietnamese drugmaker
JW Pharmaceutical said that it has taken over Euvipharm, a Vietnamese pharm...
by Lee Han-soo  |  2019-09-04 15:16
여백
여백
여백
Back to Top